KK-4277

N/A

Report date: 2024/08/06 16:45:46

Base Information

Drug NameKK-4277
Drug Alias NameKK-4277SBI-9674
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionReceptor-type tyrosine-protein phosphatase S inhibitors
TargetsReceptor-type tyrosine-protein phosphatase S
Therapy Area/IndicationsLupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSbi Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A